The role of low-income and middle-income country prisons in eliminating Hepatitis C
Loading...
Date
Authors
Akiyama, Matthew J.
Kronfli, Nadine
Cabezas, Joaquin
Sheehan, Yumi
Scheibe, Andrew
Brahni, Taha
Naik, Kunal
Mashabela, Pelmos
Chan, Polin
Luhmann, Niklas
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Hepatitis C virus (HCV) is a global health problem affecting 58 million people, 80% of whom live in low-income and middle-income countries (LMICs). In 2019, 1·5 million new HCV infections and 290 000 HCV-related deaths were estimated worldwide. One in two people who inject drugs has been exposed to HCV, and nearly half of incident HCV infections could be prevented if transmission risk due to injection drug use was removed. Mainly as a result of the criminalisation of substance use and the incarceration of people who use drugs, HCV is the most prevalent infectious disease in carceral settings worldwide. However, HCV-related data from prisons in LMICs are scarce.
Description
Keywords
Hepatitis C virus (HCV), Infections, Deaths, SDG-03: Good health and well-being, Low- and middle-income countries (LMICs), Criminalisation, Substance use, Incarceration, People who use drugs
Sustainable Development Goals
Citation
Akiyama, M.J., Kronfli, N., Cabezas, J. et al. 2022, 'The role of low-income and middle-income country prisons in eliminating hepatitis C', Lancet Public Health, vol. 7, no. 7, pp. e578-e579. DOI : 10.1016/S2468-2667(22)00119-0.